First human tests begin for new weight loss injection
NCT ID NCT07152002
Summary
This is an early-stage study to check the safety and side effects of a new drug called LY4064912, which is being developed for weight management. It will involve 144 healthy and overweight participants who will receive the drug as an injection under the skin or through an IV. Researchers will monitor for side effects and measure how the body processes the drug, including any effects on body weight and kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Collaborative Neuroscience Network - CNS
NOT_YET_RECRUITINGLos Alamitos, California, 90720, United States
Contact Phone: •••-•••-••••
Contact
-
ICON Early Phase Services
RECRUITINGSan Antonio, Texas, 78209, United States
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
RECRUITINGSingapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.